chr20-44355852-C-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_175914.5(HNF4A):c.48C>A(p.Tyr16*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_175914.5 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Maturity-onset diabetes of the young type 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Exeter Molecular Genetics Laboratory | Oct 05, 2021 | The c.48C>A variant in the HNF4 homeobox A gene, HNF4A, Results in the substitution of a tyrosine amino acid to a termination codon (p.Tyr16Ter) in exon 1 of the pancreatic specific HNF4A isoform NM_175914.5. This variant is predicted to generate an mRNA with a premature termination codon that would undergo nonsense mediated decay resulting in absent protein in a gene in which loss-of-function is an established disease mechanism (PVS1_Very Strong; PMID: 23348805). This variant is absent in gnomAD v2.1.1 (PM2_Supporting), and was identified by our laboratory in an individual with clinical history highly specific for HNF4A-MODY (MODY probability calculator result >50%, negative genetic testing for HNF1A, and antibody negative) (PP4_Moderate). This variant also segregated with diabetes in this family with 5 informative meioses (PP1_Strong). A different nucleotide change at this nucleotide position that also results in the same pathogenic p.Tyr16Ter amino acid change has been identified by this laboratory (c.48C>G) (PS1_Strong). In summary, c.48C>A meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied: PVS1_Very Strong, PS1_Strong, PP1_Strong, PP4_Moderate, PM2_Supporting. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.